Xarelto Lawsuit Plaintiffs Note Investigation Into Defective Blood Testing Device

May 29, 2016 – – TheProductLawyers.com reports on Xarelto, a very popular new-generation blood thinner released on the market in 2011 after approval by the U.S. Food and Drug Administration (FDA). The drug’s popularity was grounded in its provision of more freedoms to patients than the traditional blood thinners released before it. Xarelto was approved for the treatment of patients suffering from a variety of medical conditions such as deep vein thrombosis, pulmonary embolism, and atrial fibrillation, as well as for patients recovering from hip or knee replacement surgery.

Since the agency’s approval, however, the drug has become the focus of many lawsuits against its manufacturers, Janssen Pharmaceuticals, a division of the Johnson and Johnson Corporation, and Bayer AG. In addition to the lawsuits, a number of investigations are underway as well related to its clinical trials and over a defective medical device. The drug has also received two black box warnings from the FDA. Such warnings are the strictest and harshest warning that can be issued to a product, and usually portends a possible complete removal from the market.

The lawsuits filed number in excess of 3,400 at the moment coming from all across America with all of them being consolidated into two primary groups for litigation purposes since there were many common attributes between all the cases. The first batch is a mass tort program of more than 600 cases in Philadelphia, PA created by the Court of Common Pleas. The second group of lawsuits is a multidistrict litigation (MDL) approved by the United States Judicial Panel on Multidistrict Litigation (JPML) that encompasses over 2,800 cases. The MDL is being overseen by the Honorable Judge Eldon Fallon of the Eastern District of Louisiana. The MDL has been recorded with No. 2592.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010279